They completed a human factors study so they could get OTC clearance.
From the quarterly
A key step in this process involved completing a human factors study in the second half of FY24 to
assess usability and ensure that the Pulse’s design supports effective, independent use by
consumers. As an essential requirement for OTC clearance, this study enabled us to evaluate and
refine the user experience, validating the device’s intuitiveness and safety for use outside a clinical
setting.
- Forums
- ASX - By Stock
- Redducing morbidity in pre-eclampsia Mum's to be
CDX
cardiex limited
Add to My Watchlist
2.44%
!
4.0¢

They completed a human factors study so they could get OTC...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $17.94M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 4.0¢ | $15.12K | 377.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 155651 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 22200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 155651 | 0.040 |
1 | 15000 | 0.039 |
3 | 314000 | 0.038 |
4 | 657100 | 0.037 |
2 | 263210 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 22200 | 1 |
0.045 | 157414 | 2 |
0.050 | 100000 | 1 |
0.052 | 180000 | 1 |
0.080 | 100799 | 1 |
Last trade - 15.18pm 20/06/2025 (20 minute delay) ? |
Featured News
CDX (ASX) Chart |